Glypican-3 Immunohistochemistry reveals positive staining in the tumor nodules, similarly to what happens in humans, and in the zone 3 of the parenchyma of damaged liver in the CDAA+CCl4 group [20] (Fig. 8B). This evidence concerns the gene GPC3 and neoplasm.